Alpha-Synuclein: The Gateway to Parkinsonism - Innsbruck

Innsbruck Medical University, Innsbruck, Austria

February 11-13, 2015

Innsbruck, AustriaCourse Description

This conference featured an internationally renowned faculty of researchers, scientists and clinicians who presented on alpha-synuclein related to Parkinson’s disease and parkinsonism during the three-day event.  

The first day’s sessions highlighted genetics and environment as it is linked to alpha-synuclein, advances in PD biomarkers and non-motor aspects of Parkinson’s disease. 

The second day addressed intracellular disruption by alpha-synuclein, extracellular alpha-synuclein, and multiple system atrophy; while the third day focused on emerging therapies.   Each session included a roundtable discussion where participants were able to interact with the session’s faculty members and ask pressing questions. 

In addition, participants were invited to submit abstracts for a poster presentation on the second day – prize money was awarded to the top three presentations, as judged by the Scientific Advisory Board for the conference.

Learning Objectives

At the conclusion of this activity, participants were able to accomplish the following:

  • Define the role of alpha-synuclein in the pathogenesis of PD and MSA
  • Discuss the pros and cons of prion-like propagation in PD and related disorders
  • Identify clinical features in the premotor phase of PD and MSA
  • Critically discuss the value of biomarkers in the early diagnosis of PD and MSA
  • Review disease modification interventions in PD and MSA including immunization
Recommended Audience

This course was recommended for neuroscientists and movement disorder neurologists with an interest in alpha-synucleinopathies such as Parkinson`s disease and multiple system atrophy.

Accreditation Statement

The International Parkinson and Movement Disorder Society is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS). “Deep Brain Stimulation for Movement Disorders” is designated for a maximum of 8 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he or she actually spent in the educational activity.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™.  Click here for information on the process to convert EACCME credit to AMA credit.

EACCME Credits
This course has been accredited for 11 EACCME credits.  Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The EACCME credit system is based on 1 ECMEC per hour with a maximum of 3 ECMECs for half a day and 6 ECMECs for a full-day event.